Introduction
Calcium-Channel Drugs
Modulation of Electrical Activity and of Intracellular Calcium Oscillations of Smooth Muscle Cells by Calcium Antagonists, Agonists, and Vasopressin
Endothelin
Subcellular Localization of Calcium Release in Isolated Rat Myocardial Cells
Low-Dose Felodipine Treatment Attenuates Endothelial Dysfunction in Rabbits Fed an Atherogenic Diet
Calcium Antagonists and Cholesteryl Ester Metabolism in Macrophages
Hypercholesterolemia Modulates the Effects of Nitrendipine on Blood Pressure and Platelet Function in Essential Hypertension
Nifedipine vs. Enalapril in Treatment of Hypertensive Patients with Glucose Intolerance
Hemodynamic Profile of Ro 40–5967 in Conscious Rats
New Aspects of Calcium Antagonists for Treatment of Cerebrovascular Disease
Calcium Antagonists and the Kidney
Calcium Antagonists and Atherosclerosis
Calcium Antagonists in Antihypertensive Combination Therapy
Calcium Antagonists, Ventricular Arrhythmias, and Sudden Cardiac Death
Protective Effects of Calcium Antagonists on Energy and Substrate Metabolism During Ischemia and Reperfusion in Hypertensive Myocardial Hypertrophy
Calcium Antagonists and the Stunned Myocardium
Calcium-Channel Blockers as Adjuvant Therapy Postthrombolysis
The Antiarrhythmic and Antifibrillatory Effects of Calcium Antagonists